Tuesday, June 23, 2026
5:00 – 6:00 p.m. | Learning Gallery & Networking Reception
6:00 – 9:00 p.m. | CME Presentation
9:00 – 9:30 p.m. | Learning Gallery
* Buffet dinner will be served 5:45 – 7:00 p.m.
Indianapolis Marriott Downtown
350 W Maryland St
Indianapolis, IN 46225
Learning Gallery: Indiana Ballroom D
General Session: Indiana Ballroom A-C
PROGRAM FEATURES
-
- Interactive, case-based learning environment
- Downloadable animations
- Customize your own personalized pocket card
PRESENTING FACULTY
 |
Emily Sims M.D. M.S. Associate Professor of Pediatrics Indiana University School of Medicine Indianapolis, Indiana |
 |
Kim Pfotenhauer DO, FACOFP, DABOM Assistant Professor of Family Medicine Assistant Dean for Clerkship Education Michigan State University College of Osteopathic Medicine East Lansing, Michigan |
PROGRAM OVERVIEW
The DETECT-T1D Live Summit series will provide a practical overview of early detection and disease-modifying therapies across the type 1 diabetes (T1D) continuum. Insights from multidisciplinary expert faculty, paired with a powerful patient perspective, will aim to translate emerging evidence into actionable strategies for clinical practice. The program will cover evidence and guidance for identifying presymptomatic T1D, applying therapies that can delay disease progression, as well as exploring emerging strategies to preserve beta-cell function in new onset T1D. In addition, the program will feature dynamic discussions between the faculty and the patient advocate, interactive case-based learning, and peer-to-peer discussions, as well as an opportunity to access a learning gallery featuring additional educational tools and resources.
TARGET AUDIENCE
This activity is designed to meet the educational needs of multidisciplinary clinicians who refer, treat or see patients with or at high risk for T1D is needed, including primary care clinicians, pediatricians, pediatric & adult endocrinologists, diabetes educators, infusion professionals and other allied healthcare professionals.
LEARNING OBJECTIVES
Upon completion of this activity, attendees will have improved ability to:
- Implement risk-based screening approaches to facilitate timely identification of presymptomatic T1D.
- Analyze T1D screening results to determine disease stage and inform appropriate monitoring and referral decisions.
- Develop individualized treatment strategies that incorporate disease-modifying therapies to delay T1D progression in eligible patients.
- Recognize the importance of beta-cell preservation on T1D prognosis and outcomes.
- Review emerging approaches aimed at beta cell preservation & their potential future application in new-onset T1D
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 3.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 3.5 ANCC contact hours.
COMMISSION ON DIETETIC REGISTRATION (CDR) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 3.5 CPEU.
PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 3.5 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
